Since the first biosimilar medicine, Omnitrope® (active substance somatropin) was approved in 2006, 53 biosimilars have been authorized Spain. We estimate budget impact of Spain from perspective National Health System (NHS) over period between 2009 and 2019. Drug acquisition costs considering commercial discounts at public procurement procedures (hospital tenders) uptake data for both originato...